173 related articles for article (PubMed ID: 19889802)
21. Sex differences in renal responses to hyperglycemia, L-arginine, and L-NMMA in humans with uncomplicated type 1 diabetes.
Cherney DZ; Scholey JW; Sochett EB
Diabetes Care; 2013 May; 36(5):1290-6. PubMed ID: 23250800
[TBL] [Abstract][Full Text] [Related]
22. Improvement in Angiotensin 1-7 precedes and correlates with improvement in Arterial stiffness and endothelial function following Renin-Angiotensin system inhibition in type 2 diabetes with newly diagnosed hypertension.
Srivastava P; Badhwar S; Chandran DS; Jaryal AK; Jyotsna VP; Deepak KK
Diabetes Metab Syndr; 2020; 14(5):1253-1263. PubMed ID: 32688242
[TBL] [Abstract][Full Text] [Related]
23. Renal and cardio-protective effects of direct renin inhibition: a systematic literature review.
Lambers Heerspink HJ; Perkovic V; de Zeeuw D
J Hypertens; 2009 Dec; 27(12):2321-31. PubMed ID: 19727007
[TBL] [Abstract][Full Text] [Related]
24. Renal hemodynamic effect of cyclooxygenase 2 inhibition in young men and women with uncomplicated type 1 diabetes mellitus.
Cherney DZ; Scholey JW; Nasrallah R; Dekker MG; Slorach C; Bradley TJ; Hébert RL; Sochett EB; Miller JA
Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1336-41. PubMed ID: 18400871
[TBL] [Abstract][Full Text] [Related]
25. Effect of protein kinase Cbeta inhibition on renal hemodynamic function and urinary biomarkers in humans with type 1 diabetes: a pilot study.
Cherney DZ; Konvalinka A; Zinman B; Diamandis EP; Soosaipillai A; Reich H; Lorraine J; Lai V; Scholey JW; Miller JA
Diabetes Care; 2009 Jan; 32(1):91-3. PubMed ID: 18945921
[TBL] [Abstract][Full Text] [Related]
26. Renin release in response to Renin system blockade: activation of the Renin system in type 1 diabetes mellitus.
Stevanovic RD; Price DA; Lansang MC; Fisher ND; Laffel LM; Hollenberg NK
J Renin Angiotensin Aldosterone Syst; 2005 Sep; 6(2):78-83. PubMed ID: 16470486
[TBL] [Abstract][Full Text] [Related]
27. Effect of hyperglycaemia on arterial pressure, plasma renin activity and renal function in early diabetes.
Miller JA; Floras JS; Zinman B; Skorecki KL; Logan AG
Clin Sci (Lond); 1996 Mar; 90(3):189-95. PubMed ID: 8777824
[TBL] [Abstract][Full Text] [Related]
28. Glycosuria-mediated urinary uric acid excretion in patients with uncomplicated type 1 diabetes mellitus.
Lytvyn Y; Škrtić M; Yang GK; Yip PM; Perkins BA; Cherney DZ
Am J Physiol Renal Physiol; 2015 Jan; 308(2):F77-83. PubMed ID: 25377916
[TBL] [Abstract][Full Text] [Related]
29. Association between uric acid, renal haemodynamics and arterial stiffness over the natural history of type 1 diabetes.
Lytvyn Y; Bjornstad P; Lovshin JA; Singh SK; Boulet G; Farooqi MA; Lai V; Tse J; Cham L; Lovblom LE; Weisman A; Keenan HA; Brent MH; Paul N; Bril V; Advani A; Sochett E; Perkins BA; Cherney DZI
Diabetes Obes Metab; 2019 Jun; 21(6):1388-1398. PubMed ID: 30761725
[TBL] [Abstract][Full Text] [Related]
30. Aliskiren, a direct renin inhibitor, improves vascular endothelial function in patients on hemodialysis independent of antihypertensive effect ∼ a pilot study∼.
Moriya H; Kobayashi S; Ohtake T; Tutumi D; Mochida Y; Ishioka K; Oka M; Maesato K; Hidaka S; Nomura S
Kidney Blood Press Res; 2013; 37(2-3):190-8. PubMed ID: 23736778
[TBL] [Abstract][Full Text] [Related]
31. The acute effect of clamped hyperglycemia on the urinary excretion of inflammatory cytokines/chemokines in uncomplicated type 1 diabetes: a pilot study.
Cherney DZ; Scholey JW; Sochett E; Bradley TJ; Reich HN
Diabetes Care; 2011 Jan; 34(1):177-80. PubMed ID: 20841614
[TBL] [Abstract][Full Text] [Related]
32. Renal perfusion and the renal hemodynamic response to blocking the renin system in diabetes: are the forces leading to vasodilation and vasoconstriction linked?
Lansang MC; Hollenberg NK
Diabetes; 2002 Jul; 51(7):2025-8. PubMed ID: 12086929
[TBL] [Abstract][Full Text] [Related]
33. Effect of aliskiren on circulating endothelial progenitor cells and vascular function in patients with type 2 diabetes and essential hypertension.
Raptis AE; Markakis KP; Mazioti MC; Ikonomidis I; Maratou EP; Vlahakos DV; Kotsifaki EE; Voumvourakis AN; Tsirogianni AG; Lambadiari VA; Lekakis JP; Raptis SA; Dimitriadis GD
Am J Hypertens; 2015 Jan; 28(1):22-9. PubMed ID: 24994608
[TBL] [Abstract][Full Text] [Related]
34. The effect of aliskiren on urinary cytokine/chemokine responses to clamped hyperglycaemia in type 1 diabetes.
Cherney DZ; Reich HN; Scholey JW; Daneman D; Mahmud FH; Har RL; Sochett EB
Diabetologia; 2013 Oct; 56(10):2308-17. PubMed ID: 23893332
[TBL] [Abstract][Full Text] [Related]
35. Autonomy of the renin system in type II diabetes mellitus: dietary sodium and renal hemodynamic responses to ACE inhibition.
De'Oliveira JM; Price DA; Fisher ND; Allan DR; McKnight JA; Williams GH; Hollenberg NK
Kidney Int; 1997 Sep; 52(3):771-7. PubMed ID: 9291199
[TBL] [Abstract][Full Text] [Related]
36. Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness.
Koumaras C; Tziomalos K; Stavrinou E; Katsiki N; Athyros VG; Mikhailidis DP; Karagiannis A
J Am Soc Hypertens; 2014 Feb; 8(2):74-82. PubMed ID: 24139833
[TBL] [Abstract][Full Text] [Related]
37. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK
Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696
[TBL] [Abstract][Full Text] [Related]
38. Dapagliflozin acutely improves endothelial dysfunction, reduces aortic stiffness and renal resistive index in type 2 diabetic patients: a pilot study.
Solini A; Giannini L; Seghieri M; Vitolo E; Taddei S; Ghiadoni L; Bruno RM
Cardiovasc Diabetol; 2017 Oct; 16(1):138. PubMed ID: 29061124
[TBL] [Abstract][Full Text] [Related]
39. Empagliflozin on top of metformin treatment improves arterial function in patients with type 1 diabetes mellitus.
Lunder M; Janić M; Japelj M; Juretič A; Janež A; Šabovič M
Cardiovasc Diabetol; 2018 Dec; 17(1):153. PubMed ID: 30509271
[TBL] [Abstract][Full Text] [Related]
40. Renal functional response to protein loading in type 1 (insulin-dependent) diabetic patients on normal or high salt intake.
Lopes de Faria JB; Friedman R; de Cosmo S; Dodds RA; Mortton JJ; Viberti GC
Nephron; 1997; 76(4):411-7. PubMed ID: 9274838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
